Modulators of EphA2 and ephrina1 for the treatment of fibrosis-related disease

Details for Australian Patent Application No. 2005299354 (hide)

Owner MedImmune, Inc.

Inventors Kinch, Michael S.; Carles-Kinch, Kelly

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005299354

PCT Pub. Number WO2006/047638

Priority 60/622,517 27.10.04 US

Filing date 27 October 2005

Wipo publication date 4 May 2006

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/047638 Priority application(s): WO2006/047638

2 October 2008 Alteration of Name

  The name of the applicant has been altered to MedImmune, LLC

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005299355-Modulation of antibody specificity by tailoring the affinity to cognate antigens

2005299353-Use of modulators of EphA2 and EphrinA1 for the treatment and prevention of infections